Company Filing History:
Years Active: 1984
Title: Richard R. Smith: Innovator in Pharmaceutical Purification
Introduction
Richard R. Smith is a notable inventor based in Fayetteville, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the purification of cephalosporins. His work has implications for the development of antibiotics, which are crucial in modern medicine.
Latest Patents
Richard R. Smith holds a patent for the purification of ceforanide. The patent details a method for purifying crude cephalosporin 7-[.alpha.-(2-aminomethylphenyl)acetamido]-3-[(1-carboxymethyltetrazol-5-ylthio)methyl]-3-cephem-4-carboxylic acid. This process involves converting the compound into its salt with benzyldimethylamine, recovering the salt, and regenerating the cephalosporin in a purified form. This innovation enhances the quality and efficacy of the antibiotic.
Career Highlights
Richard R. Smith is associated with Bristol-Myers Company, where he has contributed to various pharmaceutical advancements. His expertise in purification processes has been instrumental in improving drug formulations. His work has not only advanced the field but also provided valuable insights into antibiotic development.
Collaborations
Richard has collaborated with Paul D. Sleezer, working together to enhance pharmaceutical processes and innovations. Their partnership has led to significant advancements in the purification techniques used in the industry.
Conclusion
Richard R. Smith is a distinguished inventor whose work in the purification of cephalosporins has made a lasting impact on the pharmaceutical industry. His contributions continue to influence the development of effective antibiotics, showcasing the importance of innovation in healthcare.